Selective serotonin reuptake inhibitors and tricyclic antidepressants differentially affect heart failure risk in patients with kidney failure

Clicks: 4
ID: 324720
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #47 of 127 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 127 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Although selective serotonin reuptake inhibitors (SSRIs) are the treatment of choice for dialysis patients, tricyclic antidepressants (TCAs) are still frequently prescribed in clinical practice. No studies have compared the cardiovascular outcomes of patients with kidney failure (KF) and depression prescribed SSRIs and those of patients with KF and depression prescribed TCAs. Methods Data of patients who were diagnosed with depression after being diagnosed with KF between January 2003 and December 2022 were extracted from the Korean National Health Institute Database System. The primary outcome was incident heart failure. Secondary outcomes included all-cause mortality and other cardiovascular outcomes. Results We extracted the data of 3096 patients who were prescribed a single type of antidepressant that was continued throughout the follow-up period. Among these patients, 2169 were prescribed TCAs (mean age, 59.3 years; 57.4% were male), and 927 were prescribed SSRIs (mean age, 60.5 years; 48.8% were male) after KF was diagnosed. After 1:1 propensity score matching, 844 patients remained in each group, and no significant difference in all-cause mortality was observed between patients prescribed TCAs and those prescribed SSRIs. However, the risk of incident heart failure associated with TCA use was higher than that associated with SSRI use (adjusted hazard ratio (HR) 1.21, 95% confidence interval (CI) 1.07–1.36). This result was consistent with those indicated by the unmatched multivariate adjusted analysis and landmark analysis. Conclusions Among patients who were diagnosed with depression after being diagnosed with KF, SSRI use was associated with a lower risk of incident heart failure than TCA use. Individualized antidepressant treatment strategies should be considered for patients at high risk.
Reference Key
openalex_W7202205242 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yun Seob Jung, Byoung Geun Han, Yoonjong Bae, Dong Hui Shin, Tae Sic Lee, Sang Won Hwang, Semi Hwang, Seung-Kuy Cha, Jinhee Lee, Jun Young Lee
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag255
URL
https://doi.org/10.1093/ckj/sfag255
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.